Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why I rate DERM stock a Buy.

Precedential and Key Federal Circuit Opinions - TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. v. AMNEAL PHARMACEUTICALS OF NEW ...

Teva insisted panel’s narrow interpretation of ‘claims the drug’ will have a seismic effect on the Orange Book | Stay granted while en banc rehearing is under question | Decision could reshape patent ...

In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon ...

The US Food and Drug Administration (FDA) has announced that it has banned the use of synthetic food dye Red No.3 in food, drink, and ingested medicine products, after studies in rats linked it to ...

Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...

The Food and Drug Administration has proposed moving nutrition labels to the front of most packaged foods, aiming to help consumers make healthier choices, officials said. The FDA officially unveiled ...

In the Notice Letter in January 2023, Teva stated that it intended to market a generic version of Firdapse before the expiration of multiple of Catalyst’s patents listed in the FDA Orange Book.

with the U.S. Food and Drug Administration (FDA). The petition formally requests correction of the Orange Book listings for VOQUEZNA (vonoprazan) 10 mg and 20 mg tablets to accurately reflect the ...

For this week’s edition of Friday Wind Down, WSAV’s Tina Tyus-Shaw welcomes jazz storyteller Cynthia Utterbach, bassist Reggie Carson, and percussionist Richard Hill. Michelle Mealer of the ...